CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Lifetag has created PermeAbility, a novel test for assessing intestinal permeability in patients at risk for Inflammatory Bowel Disease. This test aims to improve diagnosis and treatment decisions, addressing a significant gap in current medical practices.
Inflammatory Bowel Disease (IBD) is a form of acute inflammation to the small intestine that causes ulcers and extensive damage of the gut barrier causing it to rupture.
This causes bleedings, abdominal pain, diarrhea, and a dramatic reduction of the quality of life.
The intestinal barrier is normally a very well organised structure in which the cells are tightly connected maintaining the barrier.
Moreover, IBD lesions compromise this intestinal organization and increases intestinal permeability…
LIEFTAG LDA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
